Legend Biotech Corp (LEGN)
40.38
+1.03
(+2.62%)
USD |
NASDAQ |
Nov 14, 13:03
Legend Biotech Total Assets (Quarterly): 1.798B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.798B |
| March 31, 2024 | 1.775B |
| December 31, 2023 | 1.849B |
| September 30, 2023 | 1.839B |
| June 30, 2023 | 1.931B |
| March 31, 2023 | 1.209B |
| December 31, 2022 | 1.331B |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.041B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.119B |
| September 30, 2021 | 813.76M |
| March 31, 2021 | 615.25M |
| December 31, 2020 | 722.09M |
| September 30, 2020 | 708.64M |
| June 30, 2020 | 772.86M |
| March 31, 2020 | 364.94M |
| December 31, 2019 | 287.72M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
287.72M
Minimum
Dec 2019
1.931B
Maximum
Jun 2023
1.129B
Average
1.041B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 178.29B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| BioCryst Pharmaceuticals Inc | 491.25M |
| Biomarin Pharmaceutical Inc | 6.851B |
| National Healthcare Corp | 1.563B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 639.18M |
| Shareholders Equity (Quarterly) | 1.159B |
| Debt to Equity Ratio | 0.2516 |
| Current Ratio | 4.841 |
| Net Debt Paydown Yield | -0.06% |